- Lower volatility than the market (beta -0.63)
- Beat earnings estimates in 3 of the last 4 quarters
- Strong return on equity of 62.4%
Volatile ride for Northwest Biotherapeutics stock price on Thursday moving between $0.142 and $0.170
(Updated on Jul 16, 2026)
The Northwest Biotherapeutics stock price fell by -7.31% on the last day (Thursday, 16th Jul 2026) from $0.166 to $0.153. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 19.82% from a day low at $0.142 to a day high of $0.170. The price has fallen in 6 of the last 10 days and is down by -16.17% for this period. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $848.88 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.150 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -16.13% during the next 3 months and, with a 90% probability hold a price between $0.126 and $0.195 at the end of this 3-month period.
NWBO Signals & Forecast
There are few to no technical positive signals at the moment. The Northwest Biotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.173 and $0.191. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 13, 2026, and so far it has fallen -41.87%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Northwest Biotherapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Northwest Biotherapeutics stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0281 between high and low, or 19.82%. For the last week, the stock has had daily average volatility of 8.41%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NWBO) For The Upcoming Trading Day Of Friday 17th
For the upcoming trading day on Friday, 17th we expect Northwest Biotherapeutics to open at $0.155, and during the day (based on 14 day Average True Range), to move between $0.147 and $0.160, which gives a possible trading interval of +/-$0.0136 (+/-9.26%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 9.26% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $0.166, some $0.0121 (7.89%) from the current price of $0.153, our system finds the risk reward not very attractive.
Is Northwest Biotherapeutics stock A Buy?
Northwest Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-4.902
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 17, 2026 - $0.155 ( 1.06%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NWBO Performance
Trading levels for NWBO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.183 | 19.38% |
| R2 | 0.172 | 12.39% |
| R1 | 0.166 | 8.06% |
| Price | 0.153 | |
| S1 | 0.144 | -5.93% |
| S2 | 0.138 | -10.26% |
| S3 | 0.127 | -17.25% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.188 | 22.56% |
| R2 | 0.185 | 20.60% |
| R1 | 0.166 | 7.89% |
| Price | 0.153 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Northwest Biotherapeutics Stock.
Buy NWBO